ArticleFrontiers in pharmacology2022

HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib.

Ziwen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.